Search
Search Funnelback University
- Refined by:
- Date: Past 6 months
61 -
70 of
189
search results for `news stories`
Fully-matching results
-
Flexible wooden walls – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/opportunities/flexible-wooden-walls/4 Jan 2024: Mobile menu. Mobile menu. Search. back. back. back. back. back. Flexible wooden walls. The way we construct indoor spaces for people is currently flawed. The permanence of current buildings limits people’s freedom to change their surroundings and -
Meet our Board – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/about/our-team/our-board/20 Mar 2024: Prior to IDGVE, he was CEO of LineOne – a joint venture between United News and Media and British Telecom – which he grew into one of the UK’s largest portals and -
Our role within the Cambridge ecosystem – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/about/our-role-within-the-cambridge-ecosystem/17 May 2024: We play a key role in the Cambridge innovation ecosystem. -
Reproductive futures: Stem-cell-based embryo models | Cambridge…
https://www.festival.cam.ac.uk/events/reproductive-futures-stem-cell-based-embryo-models9 Feb 2024: The Pitt Building, Trumpington Street, CB2 1RP. In 2023, several stories about stem-cell-based embryo models hit the news, resulting in headlines such as: “Synthetic human embryo made without sperm -
A New Class of Collagen Membranes – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/opportunities/new-class-collagen-membranes/4 Jan 2024: A new collagen membrane technology has been developed by Professor Ruth Cameron and Professor Serena Best and their team that has the... -
Caring for cancer patients – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/caring-for-cancer-patients/31 Jan 2024: Interview with Umaima Malik Ahmad, CEO and co-founder of 52North, who is determined to make life better for chemotherapy patients everywhere. -
LGR5 monoclonal antibody for cancer immunotherapy – Cambridge…
https://www.enterprise.cam.ac.uk/opportunities/lgr5-de-7580-20/4 Jan 2024: A first-in-class humanised monoclonal antibody against LGR5 validated as a platform for ADC, BiTE and CAR-T therapies. Collaboration/licence -
Reinforced Bulk Superconductors – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/opportunities/reinforced-bulk-superconductors/4 Jan 2024: The Bulk Superconductivity Group at the University of Cambridge has been able to address the problems of crack formation, growth and propagation... -
Secure the future of your innovation – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/secure-the-future-of-their-innovation/24 Apr 2024: Sharing the UK’s NPSA and NCSC's Secure Innovation campaign to protect your IP, competitive advantage, and reputation. -
Frequently Asked Questions (FAQs) - Cambridge Enterprise
https://www.enterprise.cam.ac.uk/contact/faqs/26 Mar 2024: Get the answers to frequently asked questions in Cambridge Enterprise's FAQs section. Read more here.
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.